The convergence of cell biology and genetic engineering is creating fundamental new ways to impact disease. Capitalizing on these technological breakthroughs, BlueRock are advancing novel cell+gene platform to develop, manufacture, and deliver an entirely new generation of authentic and engineered cell therapies, across neurology, cardiology and immunology. Lead program is a first-in-class cellular therapy in development for the treatment of Parkinson’s disease.

Emile Nuwaysir

BlueRock Therapeutics

Emile Nuwaysir, Ph.D. is President and CEO of BlueRock. He joined BlueRock in Feb 2017, bringing nearly 20 years of experience in creating and guiding innovative life science companies from startup stage to fully integrated biotech companies. He was the President of a regenerative medicine division of Fujifilm, President of Opsis Therapeutics, CTO at Roche NimbleGen, VP of Business Development at NimbleGen Systems. Emile currently also holds positions of vice-chairman for the Alliance for Regenerative Medicine, and founder and vice-chairman of Invenra, Inc. He completed his Ph.D. from the University of Wisconsin-Madison and postdoctoral fellowships at the National Institutes of Health and UNC-Chapel Hill.

More Videos (BSW)

All Videos (BSW)

We use cookies and other technologies to collect data about your use of our site and about your browser, device and location. We process this data to help us understand how the site is used and to personalize our content and the advertising you see on this and other sites we also share this data with advertising, social media and analytics partners for the same purposes. By choosing “Accept All” you agree that we store cookies on your device and process the data for the aforementioned purposes . You may revoke your consent at any time by choosing the respective settings. For more information on the processing of personal data and what specific services we use see our Privacy Policy

Privacy Preference Center

We use cookies and other technologies to collect data about your use of our site and about your browser, device and location. We process this data to help us understand how the site is used and to personalize our content and the advertising you see on this and other sites we also share this data with advertising, social media and analytics partners for the same purposes. By choosing “Accept All” you agree that we store cookies on your device and process the data for the aforementioned purposes . You may revoke your consent at any time by choosing the respective settings. For more information on the processing of personal data and what specific services we use see our Privacy Policy

Necessary Cookies

These cookies are required to provide you with our site and its functions. Since storing these cookies is necessary for the provision of our site and its functions, you cannot disable them. If you block these cookies via you browser settings our site may not function properly.

Analyse Cookies

These cookies enable us to use website analytics in order to improve our site or provide you with personalized content. They may be set by us or by third party providers whose services we have added to our pages.

Marketing Cookies

These cookies enable us to use online marketing and advertising in order to provide you on this or on other sites with personalized advertisement. They may be set by us or by third party providers whose services we have added to our pages.